Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Squizzato

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Scientifica|November 27, 2013
New prospective for the management of low-risk pulmonary embolism: prognostic assessment, early discharge, and single-drug therapy with new oral anticoagulantsAlessandro Squizzato
European Journal of Internal Medicine|June 14, 2008
Prevention of venous thromboembolism and persistent vegetative state: A medical and an ethical issueAlessandro Squizzato
Internal and Emergency Medicine|May 19, 2011
Retinal vein occlusion: time for action has comeWalter Ageno, Alessandro Squizzato
Internal and Emergency Medicine|August 26, 2019
Reversal agents for oral anticoagulant-associated major or life-threatening bleedingMarco Moia, Alessandro Squizzato
Internal and Emergency Medicine|November 23, 2006
What is the next step in D-dimer research? Education of physiciansAlessandro Squizzato, Walter Ageno
International Journal of Surgery (London, England)|January 6, 2009
Thromboprophylaxis in day surgeryAlessandro Squizzato, Achille Venco
Thrombosis and Haemostasis|August 1, 2014
A new era for venous thromboembolism prevention in medical inpatientsAlessandro Squizzato, Walter Ageno
Nature Reviews. Neurology|October 14, 2017
Stroke: Patients with CVT urgently need high-quality evidenceNicoletta Riva, Alessandro Squizzato
Internal and Emergency Medicine|January 7, 2019
Optimal management of major bleeding on DOACs: not only reversal agentsSilvia Galliazzo, Alessandro Squizzato
Current Drug Safety|August 12, 2008
Recombinant activated factor VII as a general haemostatic agent: evidence-based efficacy and safetyAlessandro Squizzato, Walter Ageno
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Scientifica|November 27, 2013
New prospective for the management of low-risk pulmonary embolism: prognostic assessment, early discharge, and single-drug therapy with new oral anticoagulantsAlessandro Squizzato
European Journal of Internal Medicine|June 14, 2008
Prevention of venous thromboembolism and persistent vegetative state: A medical and an ethical issueAlessandro Squizzato
Internal and Emergency Medicine|May 19, 2011
Retinal vein occlusion: time for action has comeWalter Ageno, Alessandro Squizzato
Internal and Emergency Medicine|August 26, 2019
Reversal agents for oral anticoagulant-associated major or life-threatening bleedingMarco Moia, Alessandro Squizzato
Internal and Emergency Medicine|November 23, 2006
What is the next step in D-dimer research? Education of physiciansAlessandro Squizzato, Walter Ageno
International Journal of Surgery (London, England)|January 6, 2009
Thromboprophylaxis in day surgeryAlessandro Squizzato, Achille Venco
Thrombosis and Haemostasis|August 1, 2014
A new era for venous thromboembolism prevention in medical inpatientsAlessandro Squizzato, Walter Ageno
Nature Reviews. Neurology|October 14, 2017
Stroke: Patients with CVT urgently need high-quality evidenceNicoletta Riva, Alessandro Squizzato
Internal and Emergency Medicine|January 7, 2019
Optimal management of major bleeding on DOACs: not only reversal agentsSilvia Galliazzo, Alessandro Squizzato
Current Drug Safety|August 12, 2008
Recombinant activated factor VII as a general haemostatic agent: evidence-based efficacy and safetyAlessandro Squizzato, Walter Ageno
Pageof 21